KEAP1 and lung cancer: In this study, we further investigated how Nrf2 regulates motility in NSCLC cells based on our previous findings, which showed that high activation of Nrf2 due to Keap1 mutation promotes migration ability both in vitro and in vivo in EGFR-TKI resistant lung cancer cells.